Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes Article Early Access

Industry Collaboration International Collaboration

cited authors

  • Aroda, Vanita R. R.; Erhan, Umut; Jelnes, Peter; Meier, Juris J. J.; Abildlund, Morten Tind; Pratley, Richard; Vilsboll, Tina; Husain, Mansoor

authors

Publication Date

  • February 21, 2023

webpage

published in

category

keywords

  • GLP-1
  • antidiabetic drug
  • phase III study
  • randomized trial
  • type 2 diabetes